UBS Group
PHVS icon

UBS Group’s Pharvaris PHVS Stock Holding History

UBS Group’s Portfolio PHVS Stock Details PHVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$11.1M Buy
349,068
+94,278
+37% +$3.3M ﹤0.01% 3292
2026
Q2 		$8.81M Buy
254,790
+182,849
+254% +$5.53M ﹤0.01% 3588
2026
Q1 		$2.03M Sell
71,941
-65,793
-48% -$1.76M ﹤0.01% 4968
2025
Q4 		$3.82M Buy
137,734
+6,982
+5% +$168K ﹤0.01% 4306
2025
Q3 		$3.26M Buy
130,752
+127,009
+3,393% +$2.82M ﹤0.01% 4475
2025
Q2 		$65.9K Sell
3,743
-3,706
-50% -$59.7K ﹤0.01% 7553
2025
Q1 		$117K Buy
7,449
+6,404
+613% +$108K ﹤0.01% 6931
2024
Q4 		$20K Sell
1,045
-546
-34% -$11.2K ﹤0.01% 7868
2024
Q3 		$29.5K Buy
1,591
+1,424
+853% +$26K ﹤0.01% 7137
2024
Q2 		$3.14K Buy
+167
New +$3.4K ﹤0.01% 8253
2023
Q4 		– Sell
-50
Closed -$1.04K – 9759
2023
Q3 		$1.04K Sell
50
-1,250
-96% -$23K ﹤0.01% 8160
2023
Q2 		$19.7K Buy
1,300
+878
+208% +$8.49K ﹤0.01% 6875
2023
Q1 		$3.4K Sell
422
-2,378
-85% -$20.9K ﹤0.01% 8324
2022
Q4 		$31.5K Buy
+2,800
New +$14.7K ﹤0.01% 7189
2022
Q3 		– Sell
-799
Closed -$18K – 10781
2022
Q2 		$18K Buy
799
+71
+10% +$1.32K ﹤0.01% 7023
2022
Q1 		$13K Buy
728
+305
+72% +$5.38K ﹤0.01% 8067
2021
Q4 		$6K Sell
423
-231
-35% -$3.61K ﹤0.01% 9283
2021
Q3 		$12K Buy
+654
New +$11.2K ﹤0.01% 7779
2021
Q2 		– Sell
-32
Closed -$1K – 9704
2021
Q1 		$1K Buy
+32
New +$1.01K ﹤0.01% 8786

Other funds holding PHVS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Patient Square Capital
Patient Square Capital Menlo Park, California $627M AUM 115.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $109B AUM 51.53% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

UBS Group's PHVS Position: Q3 2026 in Review

UBS Group increased its Pharvaris (PHVS) stake by 37% in Q3 2026, buying an estimated $3.3M and bringing the position to 349,068 shares worth $11.1M. The position accounts for ﹤0.01% of the portfolio, ranked #3292.

UBS Group first reported a position in PHVS in Q1 2021 and has held it in 19 quarters since. 31 funds tracked by Wall St. Rank hold PHVS as of Q3 2026.

  • UBS Group held 349,068 shares of Pharvaris worth $11.1M as of Q3 2026.
  • UBS Group bought 94,278 Pharvaris shares in Q3 2026, an estimated $3.3M.
  • Pharvaris made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #3292 holding.
  • UBS Group first reported a position in Pharvaris in Q1 2021 and has held it in 19 quarters since.
  • 31 funds tracked by Wall St. Rank held Pharvaris as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.